Cover Image

Comparing treatment effectiveness and costs for bronchospasm in hospitalized children: salbutamol inhaler with spacer vs. nebulizer – a retrospective study

Introduction: The study, conducted at Sultan Ahmad Shah Medical Centre, aimed to compare outcomes in bronchospasm-treated children using metered-dose inhalers (MDIs) with spacers versus nebulizers. The primary focus was on assessing the length of stay (LOS) and treatment costs associated with each m...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdullah, Ahmad Fadzil, Syed Ahmad Alsagoff, Sharifah Aishah, Rusli, Mohammad Farhan, Muhd Helmi, Muhd Alwi
Format: Article
Language:English
English
Published: Universiti Putra Malaysia Press 2024
Subjects:
R Medicine (General)
RJ Pediatrics
RJ52 Therapeutics
Online Access:http://irep.iium.edu.my/115807/7/115807_Comparing%20treatment%20effectiveness%20and%20costs%20for%20Bronchospasm.pdf
http://irep.iium.edu.my/115807/8/115807_Comparing%20treatment%20effectiveness%20and%20costs%20for%20Bronchospasm_scopus.pdf
http://irep.iium.edu.my/115807/
https://medic.upm.edu.my/upload/dokumen/2024053109563411_0156.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.iium.irep.115807
record_format dspace
spelling my.iium.irep.1158072024-11-12T05:00:03Z http://irep.iium.edu.my/115807/ Comparing treatment effectiveness and costs for bronchospasm in hospitalized children: salbutamol inhaler with spacer vs. nebulizer – a retrospective study Abdullah, Ahmad Fadzil Syed Ahmad Alsagoff, Sharifah Aishah Rusli, Mohammad Farhan Muhd Helmi, Muhd Alwi R Medicine (General) RJ Pediatrics RJ52 Therapeutics Introduction: The study, conducted at Sultan Ahmad Shah Medical Centre, aimed to compare outcomes in bronchospasm-treated children using metered-dose inhalers (MDIs) with spacers versus nebulizers. The primary focus was on assessing the length of stay (LOS) and treatment costs associated with each modality. The hypothesis anticipated no significant differences between the MDI and nebulizer groups. Materials and methods: This retrospective cohort study, spanning from January to December 2022, involved 128 children aged between two and 12 years old. The nebulizer group data covered the period from June 2019 to March 2020, while the MDI group data spanned from March 2020 to December 2021. Patient selection utilized universal sampling, and data were extracted from patient notes. The methodology included the use of a structured pro-forma for data collection, evaluating variables such as LOS, treatment costs, cumulative salbutamol dose, heart rate, and clinical parameters. Results: The results revealed no significant difference in LOS between the two groups. However, the MDI group demonstrated lower costs compared to the nebulizer group (RM10,486.00 vs. RM12,273.00 each treatment per hospital stayed). While differences in cumulative salbutamol dose were observed, no significant distinctions were noted in other clinical parameters. Conclusion: The study concluded that MDI with a spacer showed similar ward stay durations but with lower costs compared to nebulizers. This underscores the economic and practical benefits of using MDI, including a reduced risk of disease transmission and decreased nursing workloads. Universiti Putra Malaysia Press 2024-05 Article PeerReviewed application/pdf en http://irep.iium.edu.my/115807/7/115807_Comparing%20treatment%20effectiveness%20and%20costs%20for%20Bronchospasm.pdf application/pdf en http://irep.iium.edu.my/115807/8/115807_Comparing%20treatment%20effectiveness%20and%20costs%20for%20Bronchospasm_scopus.pdf Abdullah, Ahmad Fadzil and Syed Ahmad Alsagoff, Sharifah Aishah and Rusli, Mohammad Farhan and Muhd Helmi, Muhd Alwi (2024) Comparing treatment effectiveness and costs for bronchospasm in hospitalized children: salbutamol inhaler with spacer vs. nebulizer – a retrospective study. Malaysian Journal of Medicine and Health Sciences, 20 (Suppl. 3). pp. 73-79. ISSN 1675-8544 E-ISSN 2636-9346 https://medic.upm.edu.my/upload/dokumen/2024053109563411_0156.pdf 10.47836/mjmhs20.s3.11
institution Universiti Islam Antarabangsa Malaysia
building IIUM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider International Islamic University Malaysia
content_source IIUM Repository (IREP)
url_provider http://irep.iium.edu.my/
language English
English
topic R Medicine (General)
RJ Pediatrics
RJ52 Therapeutics
spellingShingle R Medicine (General)
RJ Pediatrics
RJ52 Therapeutics
Abdullah, Ahmad Fadzil
Syed Ahmad Alsagoff, Sharifah Aishah
Rusli, Mohammad Farhan
Muhd Helmi, Muhd Alwi
Comparing treatment effectiveness and costs for bronchospasm in hospitalized children: salbutamol inhaler with spacer vs. nebulizer – a retrospective study
description Introduction: The study, conducted at Sultan Ahmad Shah Medical Centre, aimed to compare outcomes in bronchospasm-treated children using metered-dose inhalers (MDIs) with spacers versus nebulizers. The primary focus was on assessing the length of stay (LOS) and treatment costs associated with each modality. The hypothesis anticipated no significant differences between the MDI and nebulizer groups. Materials and methods: This retrospective cohort study, spanning from January to December 2022, involved 128 children aged between two and 12 years old. The nebulizer group data covered the period from June 2019 to March 2020, while the MDI group data spanned from March 2020 to December 2021. Patient selection utilized universal sampling, and data were extracted from patient notes. The methodology included the use of a structured pro-forma for data collection, evaluating variables such as LOS, treatment costs, cumulative salbutamol dose, heart rate, and clinical parameters. Results: The results revealed no significant difference in LOS between the two groups. However, the MDI group demonstrated lower costs compared to the nebulizer group (RM10,486.00 vs. RM12,273.00 each treatment per hospital stayed). While differences in cumulative salbutamol dose were observed, no significant distinctions were noted in other clinical parameters. Conclusion: The study concluded that MDI with a spacer showed similar ward stay durations but with lower costs compared to nebulizers. This underscores the economic and practical benefits of using MDI, including a reduced risk of disease transmission and decreased nursing workloads.
format Article
author Abdullah, Ahmad Fadzil
Syed Ahmad Alsagoff, Sharifah Aishah
Rusli, Mohammad Farhan
Muhd Helmi, Muhd Alwi
author_facet Abdullah, Ahmad Fadzil
Syed Ahmad Alsagoff, Sharifah Aishah
Rusli, Mohammad Farhan
Muhd Helmi, Muhd Alwi
author_sort Abdullah, Ahmad Fadzil
title Comparing treatment effectiveness and costs for bronchospasm in hospitalized children: salbutamol inhaler with spacer vs. nebulizer – a retrospective study
title_short Comparing treatment effectiveness and costs for bronchospasm in hospitalized children: salbutamol inhaler with spacer vs. nebulizer – a retrospective study
title_full Comparing treatment effectiveness and costs for bronchospasm in hospitalized children: salbutamol inhaler with spacer vs. nebulizer – a retrospective study
title_fullStr Comparing treatment effectiveness and costs for bronchospasm in hospitalized children: salbutamol inhaler with spacer vs. nebulizer – a retrospective study
title_full_unstemmed Comparing treatment effectiveness and costs for bronchospasm in hospitalized children: salbutamol inhaler with spacer vs. nebulizer – a retrospective study
title_sort comparing treatment effectiveness and costs for bronchospasm in hospitalized children: salbutamol inhaler with spacer vs. nebulizer – a retrospective study
publisher Universiti Putra Malaysia Press
publishDate 2024
url http://irep.iium.edu.my/115807/7/115807_Comparing%20treatment%20effectiveness%20and%20costs%20for%20Bronchospasm.pdf
http://irep.iium.edu.my/115807/8/115807_Comparing%20treatment%20effectiveness%20and%20costs%20for%20Bronchospasm_scopus.pdf
http://irep.iium.edu.my/115807/
https://medic.upm.edu.my/upload/dokumen/2024053109563411_0156.pdf
_version_ 1816129645850918912
score 13.223943

Similar Items